Nav: Home

Routine blood tests could predict diabetes

July 19, 2019

Random plasma glucose tests could be used to predict which patients will develop diabetes, according to a study of Veterans Affairs treatment data. Researchers from several VA systems showed that levels of glucose found during standard outpatient medical testing revealed patients' likelihood of developing diabetes over the next five years, even when glucose levels did not rise to the level of diabetes diagnosis.

The findings could lead to earlier treatment and better outcomes. The research shows that glucose levels that normally would not be seen as indicating diabetes risk can in fact predict the disease's development. According to the researchers, using plasma glucose levels in blood samples taken during regular doctor visits "could signal the need for further testing, allow preventive intervention in high risk individuals before onset of disease, and lead to earlier identification of diabetes."

The results appear in the July 19, 2019, issue of PLOS ONE.

Diabetes is a major health problem in the United States, yet over 7 million Americans with diabetes go undiagnosed, according to the Centers for Disease Control and Prevention. Early diagnosis allows the use of lifestyle changes or medications that could help prevent or delay the progression from prediabetes to diabetes and help keep diabetes from worsening. When diagnosis is delayed, diabetes-related complications could develop before treatment starts.

"Although screening for prediabetes and diabetes could permit earlier detection and treatment, many in the at-risk population do not receive the necessary screening," notes Dr. Mary Rhee, lead author on the study and a physician-researcher with the Atlanta VA Health Care System and Emory University.

The American Diabetes Association recommends testing for diabetes using a few different methods: a fasting glucose level, an oral glucose tolerance test (which requires fasting and ingestion of a glucose load), a HgbA1c level (a measure of average blood glucose levels over the previous two to three months), or a random plasma glucose when accompanied by symptoms caused by high glucose levels. A random plasma glucose of 200 mg/dL (milligrams per deciliter) or higher is usually the threshold for a diagnosis of diabetes. It can be done at any time, and does not require fasting or withholding meals.

These tests are frequently included in routine labwork patients undergo during or after outpatient medical appointments. However, since many patients are not fasting when they get their blood drawn, routine blood tests with random glucose levels below 200 mg/dL have not previously been deemed useful for diabetes screening.

VA researchers examined data on these routine blood tests to see whether random plasma glucose levels could in fact predict which patients would develop diabetes in the future. They studied data on more than 900,000 VA patients who were not already diagnosed with diabetes. All patients had at least three random plasma glucose tests during a single year. Most of these tests were likely obtained "opportunistically"--that is, during regular doctor visits not specifically related to diabetes screening.

Over a five-year follow-up, about 10% of the total study group developed diabetes. Elevated random plasma glucose levels, though not meeting the diagnostic threshold for diabetes, accurately predicted the development of diabetes within the following five years. Patients with at least two random plasma glucose measurements of 115 mg/dL or higher within a 12-month period were highly likely to be diagnosed with diabetes within a few years. Glucose levels of 130 mg/dL or higher were even more predictive of diabetes.

As expected, demographics and risk factors known to be related to diabetes also predicted development of the disease. Demographic factors included age, sex, and race. Other risk factors that predicted diabetes included a high body mass index (BMI), smoking, and high cholesterol. However, random plasma glucose tests were stronger predictors of diabetes than demographics or other risk factors, alone or combined.

Development of diabetes was infrequent in subjects whose highest random plasma glucose levels were below 110 mg/dL.

In light of these findings, the researchers recommend that patients receive follow-up diagnostic testing for diabetes, such as a fasting glucose or A1c test, if they have two random glucose tests showing levels 115 mg/dL or higher. This approach would very likely be cost-effective, they say, because clinicians can use testing that is already being done during routine outpatient visits. Using random glucose levels for screening could identify patients at higher risk for diabetes, leading to earlier intervention to prevent or control the disease.

"These findings have the potential to impact care in the VA and in the general U.S. population," explains Rhee, "as random plasma glucose levels--which are convenient, low-cost, and 'opportunistic'--could appropriately prompt high-yield, focused diagnostic testing and improve recognition and treatment of prediabetes and early diabetes."
-end-
The study included VA researchers from three VA health care systems: Atlanta, Boston, and Eastern Colorado. Members of the team were also affiliated with Emory University, the University of Colorado, Brigham and Women's Hospital, Harvard Medical School, and Boston University. The research was funded by VA Clinical Science Research and Development.

Veterans Affairs Research Communications

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab